Model Number HARMONY-DCS |
Device Problems
Use of Device Problem (1670); Activation, Positioning or Separation Problem (2906); Difficult to Advance (2920)
|
Patient Problems
Hemorrhage/Bleeding (1888); Perforation of Vessels (2135)
|
Event Date 11/19/2021 |
Event Type
Injury
|
Event Description
|
Medtronic received information that during the implant of this transcatheter pulmonary bioprosthetic valve, in a patient with an existing defibrillator, while placing the valve the atrial lead was dislodged and the atrium was perforated.The procedure was converted to a surgical procedure to stabilize the bleed.No additional adverse patient effects were reported.
|
|
Manufacturer Narrative
|
Product analysis: no product was returned. conclusion: without the return of the product, no definitive conclusion can be made regarding the clinical observation.If information is provided in the future, a supplemental report will be issued.
|
|
Manufacturer Narrative
|
Additional information was received that there was a stent in the left pulmonary artery (lpa) that was inhibiting the delivery catheter system (dcs) from entering into the right pulmonary artery (rpa).While applying forward pressure of the dcs, the atrial lead was dislodged.Updated: h6.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Manufacturer Narrative
|
Additional information was received that there was a stent in the left pulmonary artery (lpa) that was inhibiting the delivery catheter system (dcs) from entering into the right pulmonary artery (rpa).While applying forward pressure of the dcs, the atrial lead was dislodged.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Manufacturer Narrative
|
Conclusion: the subject delivery catheter system (dcs) was not returned and no procedural images were submitted for review.The lot number of the dcs is not known; therefore, a device history record review could not be performed.However, manufacturing controls are in place to ensure the device met specification requirements prior to release from the manufacturing facility.Difficulties advancing the dcs is known to be related to procedural factors, user technique, and/or patient anatomy (angulation, calcification, tortuosity, etc.).Vascular complications, such as bleeding and perforation, are a known potential adverse patient effect per the ifu, and are typically related to patient factors (anatomy, comorbidities, etc.), and/or procedural effects (sheath used, user technique, puncture cut location, etc.).Per the device instructions for use (ifu), the user is instructed not to advance any portion of the dcs under resistance and to identify the cause of resistance using fluoroscopy and take appropriate action to remedy the problem before continuing to advance the dcs.As the report indicates that forward pressure was applied to advance the dcs this would suggest ¿off label¿ use.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Search Alerts/Recalls
|
|